BridgeBio Pharma Inc (NASDAQ:BBIO)

14.32
Delayed Data
As of 3:59pm ET
 -0.58 / -3.89%
Today’s Change
4.98
Today|||52-Week Range
19.95
+87.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.3B

Company Description

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Contact Information

BridgeBio Pharma, Inc.
3160 Porter Drive
Palo Alto California 94304
P:(650) 391-9740
Investor Relations:

Employees

Shareholders

Other institutional52.99%
Individual stakeholders52.80%
Mutual fund holders21.79%

Top Executives

Neil KumarChief Executive Officer & Director
Jonathan C. FoxPresident & Chief Medical Officer
Christine E. SiuChief Operating Officer
Brian C. StephensonChief Financial Officer & Secretary
Uma SinhaChief Scientific Officer